Literature DB >> 22396160

Klotho and βKlotho.

Makoto Kuro-o1.   

Abstract

Endocrine fibroblast growth factors (FGFs) have been recognized as hormones that regulate a variety of metabolic processes. FGF19 is secreted from intestine upon feeding and acts on liver to suppress bile acid synthesis. FGF21 is secreted from liver upon fasting and acts on adipose tissue to promote lipolysis and responses to fasting. FGF23 is secreted from bone and acts on kidney to inhibit phosphate reabsorption and vitamin D synthesis. One critical feature of endocrine FGFs is that they require the Klotho gene family of transmembrane proteins as coreceptors to bind their cognate FGF receptors and exert their biological activities. This chapter overviews function of Klotho family proteins as obligate coreceptors for endocrine FGFs and discusses potential link between Klothos and age-related diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22396160     DOI: 10.1007/978-1-4614-0887-1_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  40 in total

1.  Unliganded fibroblast growth factor receptor 1 forms density-independent dimers.

Authors:  Laëtitia Comps-Agrar; Diana Ronai Dunshee; Dan L Eaton; Junichiro Sonoda
Journal:  J Biol Chem       Date:  2015-08-13       Impact factor: 5.157

2.  Loss of Klotho contributes to kidney injury by derepression of Wnt/β-catenin signaling.

Authors:  Lili Zhou; Yingjian Li; Dong Zhou; Roderick J Tan; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2013-04-04       Impact factor: 10.121

Review 3.  The emerging role of Klotho in clinical nephrology.

Authors:  Ming Chang Hu; Makoto Kuro-o; Orson W Moe
Journal:  Nephrol Dial Transplant       Date:  2012-07       Impact factor: 5.992

4.  Structures of ligand-occupied β-Klotho complexes reveal a molecular mechanism underlying endocrine FGF specificity and activity.

Authors:  Ekaterina S Kuzina; Peter Man-Un Ung; Jyotidarsini Mohanty; Francisco Tome; Jungyuen Choi; Els Pardon; Jan Steyaert; Irit Lax; Avner Schlessinger; Joseph Schlessinger; Sangwon Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-03       Impact factor: 11.205

5.  Klotho Ameliorates Kidney Injury and Fibrosis and Normalizes Blood Pressure by Targeting the Renin-Angiotensin System.

Authors:  Lili Zhou; Hongyan Mo; Jinhua Miao; Dong Zhou; Roderick J Tan; Fan Fan Hou; Youhua Liu
Journal:  Am J Pathol       Date:  2015-10-24       Impact factor: 4.307

6.  Regulation of mineral metabolism by lithium.

Authors:  Hajar Fakhri; Ganesh Pathare; Abul Fajol; Bingbing Zhang; Thomas Bock; Reinhard Kandolf; Erwin Schleicher; Jürg Biber; Michael Föller; Undine E Lang; Florian Lang
Journal:  Pflugers Arch       Date:  2013-09-07       Impact factor: 3.657

7.  Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.

Authors:  J M Gallego-Escuredo; J Gómez-Ambrosi; V Catalan; P Domingo; M Giralt; G Frühbeck; F Villarroya
Journal:  Int J Obes (Lond)       Date:  2014-05-12       Impact factor: 5.095

8.  Elevated Fibroblast Growth Factor 23 Concentration: Prediction of Mortality among Chronic Kidney Disease Patients.

Authors:  Shahanas Chathoth; Samir Al-Mueilo; Cyril Cyrus; Chittibabu Vatte; Awatif Al-Nafaie; Rudaynah Al-Ali; Brendan J Keating; Fahad Al-Muhanna; Amein Al Ali
Journal:  Cardiorenal Med       Date:  2015-11-04       Impact factor: 2.041

Review 9.  FGF23 associated bone diseases.

Authors:  Eryuan Liao
Journal:  Front Med       Date:  2013-03-09       Impact factor: 4.592

10.  Effect of chronic uremia on the transcriptional profile of the calcified aorta analyzed by RNA sequencing.

Authors:  Jakob L Rukov; Eva Gravesen; Maria L Mace; Jacob Hofman-Bang; Jeppe Vinther; Claus B Andersen; Ewa Lewin; Klaus Olgaard
Journal:  Am J Physiol Renal Physiol       Date:  2016-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.